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Endogenous Opiate Alkaloids and Human Skin
To the Editor:
Endogenous morphine and codeine have been identi®ed in the
central nervous system and a variety of peripheral tissues (e.g.,
heart, adrenal, and skin) (Donnerer et al, 1987). Mammalian tissues
not only contain morphine and codeine, but also synthesize these
opiate alkaloids (Donnerer et al, 1986; Weitz et al, 1987). Studies
also indicate a physiologic role in mammals for these agents as drugs
and experimental manipulations (e.g., fasting) can alter the levels of
morphine and codeine (Horak et al, 1993; Lee and Spector, 1991).
In terms of ligand af®nity, morphine is the prototypic agonist for
the m-opiate receptor (Pasternak, 1993).
It is in this context we read with great interest the paper entitled
``Expression of m-Opiate Receptor in Human Epidermis and
Keratinocytes'' in the Journal of Investigative Dermatology (Bigliardi et
al, 1998). When the investigators examined the role of the
epidermal keratinocyte in the interface of neurologic, immune, and
dermatologic systems, they cited evidence for the production of
proopiomelanocortin (POMC) by human epidermal keratinocytes
(Schauer et al, 1994). A derivative of POMC is b-endorphin. They
hypothesized that given the presence of b-endorphin keratinocytes
might contain opiate receptors. In a series of experiments they
demonstrated that human epidermal keratinocytes expressed the
mRNA and protein (detected by immunohistochemistry) for the
m-opiate receptor. Given the correlation between the locations of
the mRNA and protein, they concluded that the m-opiate receptor
is both transcribed and functional. To demonstrate the latter point
human skin cultures were incubated with naloxone or b-endorphin
with subsequent downregulation of the m-opiate receptor com-
pared to control. An extension of this research (Bigliardi-Qi et al,
2000) provided data supporting the association of the m-opiate
receptor and b-endorphin in the pathogenesis of psoriasis.
Given that morphine has a greater af®nity for the m-opiate
receptor than b-endorphin and the presence of these receptors in
the epidermis, we investigated the interaction of endogenous
morphine with this receptor, utilizing neonatal foreskin samples. A
rabbit-derived polyclonal antimorphine antibody obtained from S.
Spector (Oka et al, 1985) was used in this study. This antibody did
not recognize any of the opioid peptides (enkephalins, endorphins,
dynorphins, and their fragments), did not bind to the narcotic
antagonists naloxone or naltrexone (unpublished data), and was
therefore considered speci®c for morphine. This antibody was used
to detect immunoreactive morphine in the foreskin samples. The
results indicated a selective localization of ligand in the epidermis,
more pronounced in the basal layer (Fig 1). These preliminary
results suggest that endogenous morphine is a functionally active
physiologic ligand for the m-opiate keratinocyte receptor in human
skin.
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Figure 1. Immunoperoxidase staining of neonatal foreskin with
antimorphine antibody. (A) Presence of primary antibody; (B) absence
of primary antibody. Magni®cation 403.
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